Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-22
2008-07-22
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S492000
Reexamination Certificate
active
07402604
ABSTRACT:
Compounds according to formula I:wherein R1, W, R2, R3, X, R4and R5are as described in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission.
REFERENCES:
patent: 5690697 (1997-11-01), Samain
patent: 6750242 (2004-06-01), Gurley et al.
patent: 0237781 (1987-09-01), None
patent: 0722941 (1996-07-01), None
patent: 1310235 (1973-03-01), None
patent: WO 9205170 (1992-04-01), None
patent: WO 9311106 (1993-06-01), None
patent: WO 9318026 (1993-09-01), None
patent: WO 9530655 (1995-11-01), None
Phytochemistry, vol. 11, 1972, Torigoe, et al. “Cytokinin Activity of Azaindene . . . and Indole Derivatives”, pp. 1623-1630, see cmpds (XIII & (XIV), p. 1625.
Chem Abstracts, vol. 57, (Columbus, Ohio, USA), Piers et al. “The Synthesis of Mercaptoindoles”, Abst No. 15053h, Can. J. Chem. 1962, 40, 511-517.
Goodman & Gilman's , “The Pharmaceutical Basis of Therapeutics,” 10th Edition, 2001, p. 549.
Gurley David
Rosamond James
Astrazeneca AB
Mitchell Kenneth F.
Saeed Kamal A
LandOfFree
Positive modulators of nicotinic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Positive modulators of nicotinic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Positive modulators of nicotinic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2780803